X-13746826-CAA-CA
Position:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_003611.3(OFD1):βc.710delAβ(p.Lys237fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000667 in 1,065,099 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.0 ( 0 hom., 0 hem., cov: 23)
Exomes π: 0.000067 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
OFD1
NM_003611.3 frameshift
NM_003611.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.15
Genes affected
OFD1 (HGNC:2567): (OFD1 centriole and centriolar satellite protein) This gene is located on the X chromosome and encodes a centrosomal protein. A knockout mouse model has been used to study the effect of mutations in this gene. The mouse gene is also located on the X chromosome, however, unlike the human gene it is not subject to X inactivation. Mutations in this gene are associated with oral-facial-digital syndrome type I and Simpson-Golabi-Behmel syndrome type 2. Many pseudogenes have been identified; a single pseudogene is found on chromosome 5 while as many as fifteen have been found on the Y chromosome. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant X-13746826-CA-C is Pathogenic according to our data. Variant chrX-13746826-CA-C is described in ClinVar as [Pathogenic]. Clinvar id is 41142.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-13746826-CA-C is described in Lovd as [Pathogenic]. Variant chrX-13746826-CA-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OFD1 | NM_003611.3 | c.710delA | p.Lys237fs | frameshift_variant | 8/23 | ENST00000340096.11 | NP_003602.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OFD1 | ENST00000340096.11 | c.710delA | p.Lys237fs | frameshift_variant | 8/23 | 1 | NM_003611.3 | ENSP00000344314.6 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 106939Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 30647 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
106939
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
30647
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000667 AC: 71AN: 1065099Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 342117
GnomAD4 exome
AF:
AC:
71
AN:
1065099
Hom.:
Cov.:
29
AF XY:
AC XY:
0
AN XY:
342117
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 106939Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 30647
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
106939
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
30647
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
OFD1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 11, 2024 | The OFD1 c.710delA variant is predicted to result in a frameshift and premature protein termination (p.Lys237Serfs*6). This variant has been reported as having arisen de novo in at least two individuals with oral-facial-digital syndrome type 1 (Prattichizzo et al. 2008. PubMed ID: 18546297; Alby et al. 2018. PubMed ID: 29193896). This variant is reported in 0.068% of alleles in individuals of Latino descent in gnomAD; however, the quality of data at this position is questionable and should be interpreted with caution. Frameshift variants in OFD1 are expected to be pathogenic. This variant is classified as pathogenic. - |
COACH syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Credence Genomics | - | - - |
Orofaciodigital syndrome I Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Dec 21, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with orofaciodigital syndrome I (MIM#311200). (I) 0108 - This gene is associated with both recessive and dominant disease. Most conditions associated with this gene are X-linked recessive; however, orofaciodigital syndrome I (MIM#311200) is X-linked dominant. (I) 0115 - Variants in this gene are known to have variable expressivity. The same variants have been associated with several OFD1-related conditions and are known to have intrafamilial and interfamilial variability (PMID: 31373179; PMID: 23033313). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v2) <0.001; however, the data quality of this variant is poor in gnomAD and is likely to be an artefact. (I) 0701 - Other NMD predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported in ClinVar as pathogenic, and reported as de novo in at least two individuals with OFDI syndrome (PMID: 29193896, PMID: 18546297). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Familial aplasia of the vermis;C1510460:Orofaciodigital syndrome I Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 01, 2022 | The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 41142). This premature translational stop signal has been observed in individual(s) with oral-facial-digital syndrome type I (PMID: 18546297). In at least one individual the variant was observed to be de novo. This sequence change creates a premature translational stop signal (p.Lys237Serfs*6) in the OFD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OFD1 are known to be pathogenic (PMID: 16783569, 18546297, 27081566). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: -46
Find out detailed SpliceAI scores and Pangolin per-transcript scores at